T0	Outcomes 850 951	tumor response defined by â‰¥ 50% reduction in serum CA125 from baseline sustained for at least 28 days
T1	Outcomes 1132 1140	in CA125
T2	Outcomes 1273 1316	no symptomatic VTE or major bleeding events
T3	Outcomes 1351 1366	experienced VTE
T4	Outcomes 1449 1539	of D-dimer and thrombin-antithrombin, and higher levels of tissue factor pathway inhibitor
T5	Outcomes 1585 1592	is safe
T6	Outcomes 1597 1611	well tolerated